Unknown PHASE3 INTERVENTIONAL NCT00127582

RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy

Evaluation of Arrhythmic Risk in Myotonic Dystrophy Type I (DM 1)

Sponsor: Catholic University of the Sacred Heart

Conditions Myotonic Dystrophy Sudden Cardiac Death

Interventions Electrophysiological study pacemaker (PM) implant, internal cardiac defibrillator (ICD) implant, loop-recorder implant

Updated 5 times since 2017 Last updated: Aug 24, 2005 Started: Jan 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Myotonic Dystrophy and Sudden Cardiac Death, this trial is ongoing. The trial is conducted by Catholic University of the Sacred Heart and has accumulated 5 data snapshots since 2003. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Catholic University of the Sacred Heart
Fondazione Telethon

Data source: Catholic University of the Sacred Heart

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy